a public good project by the
Synthesis
Company
of California

© 2026

Peter J. Kushner | doi.page

0 works0 citations0 h-index

Peter J. Kushner

Olema Pharmaceuticals (United States)(US)

Publications by Year

Research Areas

Estrogen and related hormone effects, Retinoids in leukemia and cellular processes, Cytokine Signaling Pathways and Interactions, Advanced Breast Cancer Therapies, Computational Drug Discovery Methods

Most-Cited Works

→ The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen(1998)2,696 cited
→ Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites(1997)1,854 cited
→ Structure and specificity of nuclear receptor–coactivator interactions(1998)925 cited
→ Estrogen receptor pathways to AP-1(2000)860 cited
→ Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.(1995)759 cited
→ Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.(1995)662 cited

→ Hormone-Dependent Coactivator Binding to a Hydrophobic Cleft on Nuclear Receptors(1998)

580 cited

→ Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression(2002)424 cited

→ Nuclear Receptor-Binding Sites of Coactivators Glucocorticoid Receptor Interacting Protein 1 (GRIP1) and Steroid Receptor Coactivator 1 (SRC-1): Multiple Motifs with Different Binding Specificities(1998)415 cited

→ The Estrogen Receptor Enhances AP-1 Activity by Two Distinct Mechanisms with Different Requirements for Receptor Transactivation Functions(1999)382 cited